Neuman Manuela G, Cohen Lawrence B, Nanau Radu M
In Vitro Drug Safety and Biotechnology, University of Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Canada.
Department of Internal Medicine, Faculty of Medicine, University of Toronto, Canada; Division of Gastroenterology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
Clin Biochem. 2015 Jul;48(10-11):716-39. doi: 10.1016/j.clinbiochem.2015.04.006. Epub 2015 Apr 17.
Quinolones are broad spectrum antibiotics that are intensively used and can induce immediate- and delayed-type hypersensitivity reactions, either IgE or T-cell mediated, in about 2-3% of treated patients.
To better understand how T cells interact with quinolones to produce the hypersensitivity and to describe the possible prevention of the reactions.
We search in PubMed for quinolones and adverse reactions naming each one of the therapeutics in use and the possible hypersensitivity reactions e.g., anaphylaxis, drug-induced delayed reactions, and hypersensitivity syndrome reactions. We also performed a search on organ-specific hypersensitivity reactions including cutaneous reactions, hepatic reactions, and renal reactions.
Our data show that T cells are involved in delayed immune reactions to quinolones and that cross-reactivity among the different quinolones is frequent. The predictive tests for quinolone-induced hypersensitivity should be used in patients before they are given the medication.
Early identification of the mechanism of toxicity, quantitative assessment using laboratory tests, analysis of risk factors for patient susceptibility to the quinolones, and possible drug-drug interactions may lead to appropriate patient selection for therapy, monitoring the injury early and discontinuation of the therapeutic agent.
喹诺酮类是广泛使用的广谱抗生素,在约2%至3%的接受治疗的患者中可引发即刻型和迟发型超敏反应,这些反应由IgE或T细胞介导。
为了更好地理解T细胞如何与喹诺酮类相互作用以产生超敏反应,并描述这些反应可能的预防方法。
我们在PubMed中搜索喹诺酮类及不良反应,列出每种正在使用的治疗药物以及可能的超敏反应,如过敏反应、药物诱导的迟发反应和超敏综合征反应。我们还对包括皮肤反应、肝脏反应和肾脏反应在内的器官特异性超敏反应进行了搜索。
我们的数据表明,T细胞参与了对喹诺酮类的迟发性免疫反应,并且不同喹诺酮类之间的交叉反应很常见。喹诺酮类诱导的超敏反应的预测性检测应在患者用药前使用。
早期识别毒性机制、使用实验室检测进行定量评估、分析患者对喹诺酮类易感性的危险因素以及可能的药物相互作用,可能会导致为治疗选择合适的患者、早期监测损伤以及停用治疗药物。